ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
about
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studiesA Ca(2+)-dependent signalling circuit regulates influenza A virus internalization and infection.Nitrergic and purinergic mechanisms evoke inhibitory neuromuscular transmission in the human small intestine.Differential functional role of purinergic and nitrergic inhibitory cotransmitters in human colonic relaxation.
P2860
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@en
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@nl
type
label
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@en
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@nl
prefLabel
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@en
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@nl
P2093
P2860
P356
P1476
ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
@en
P2093
D MacMillan
J G McCarron
P2860
P304
P356
10.1242/JCS.108498
P407
P577
2012-08-16T00:00:00Z